HBX Group, a leading TravelTech B2B ecosystem player, announced today that Chief Financial Officer Andrés García-Tenorio will leave his role and step away from the business over the next 12 months, following a planned succession process. The company has appointed Brendan Brennan, former CFO of ICON plc, as the new CFO, effective October 2024.
For the past 20 years, Andrés García-Tenorio has guided the business through various economic cycles with his steady leadership and financial expertise, achieving a robust financial position marked by substantial cash reserves, an improved credit rating, and a period of significant growth and transformation.
Nicolas Huss, CEO of HBX Group, said: “Andrés has been instrumental in building the substantial financial foundation we have today. His dedication and strategic vision have positioned us for continued success. We thank him for his excellent contributions to the business and wish him all the best in his future endeavours.”
Brendan Brennan joins HBX Group from ICON plc, a publicly listed global clinical research provider, where he served as CFO for the past 13 years. Brendan brings a wealth of experience in financial management, mergers & acquisitions, and investor relations.
Brendan Brennan commented: “I am thrilled to join HBX Group and work alongside such a dynamic team. I look forward to contributing to the company’s continued growth trajectory, expansion plans, and strategic initiatives.”
Nicolas Huss added: “We are excited to welcome Brendan to HBX Group. His extensive experience and proven track record in financial leadership as part of a global publicly listed company make him the ideal successor to Andrés. We are confident that Brendan will play a pivotal role in achieving our future growth ambitions.”
Andrés García-Tenorio will dedicate time to future personal projects but will remain available for a 12-month transition period to support Brendan in the role.
BRENDAN BRENNAN PROFILE:
Brendan is a strategic-minded senior executive with extensive experience driving outperformance at revenue and earnings levels global organisations. He has a proven track record of cost management, efficiency creation, and significant M&A experience, including the $12 billion acquisition and integration of PRA Health Sciences.
Brendan brings extensive experience in public listed companies including investor relations, board-level reporting, and presenting to public company sub-committees. He has worked with teams across the Americas, Europe, and Asia, managing a 41,000-FTE organisation.
Prior to his role at ICON, Brendan held various senior positions in financial planning, corporate finance, and investor relations. He has also worked with CRH Plc and PWC.
.jpg){kind=tracking}
